Erratum to: Looking forward to new targeted treatments for chronic spontaneous urticaria

Erratum to: Looking forward to new targeted treatments for chronic spontaneous urticaria

Bibliographic Details
Main Authors:	Emek Kocatürk, Marcus Maurer, Martin Metz, Clive Grattan
Format:	Article
Language:	English
Published:	Wiley 2017-04-01
Series:	Clinical and Translational Allergy
Online Access:	http://link.springer.com/article/10.1186/s13601-017-0148-9

Similar Items

Is chronic urticaria more than skin deep?
by: Emek Kocatürk, et al.
Published: (2019-09-01)

A global perspective on stepping down chronic spontaneous urticaria treatment: Results of the Urticaria Centers of Reference and Excellence SDown‐CSU study
by: Murat Türk, et al.
Published: (2024-02-01)

Differential diagnosis between urticarial vasculitis and chronic spontaneous urticaria: An international Delphi survey
by: Karoline Krause, et al.
Published: (2023-10-01)

Coexistence of granuloma annulare and chronic spontaneous urticaria
by: Ilteris Oguz Topal, et al.
Published: (2016-08-01)

Validation of the Turkish version of the Urticaria Control Test: Correlation with other tools and comparison between spontaneous and inducible chronic urticaria
by: Emek Kocatürk, et al.
Published: (2019-01-01)

Chronic urticaria and the pathogenic role of mast cells
by: Daniel Elieh-Ali-Komi, et al.
Published: (2023-07-01)

In chronic spontaneous urticaria soluble FcεRI is elevated and linked to atopy and chronic inducible urticaria
by: Sherezade Moñino‐Romero, et al.
Published: (2023-07-01)

How Infection and Vaccination Are Linked to Acute and Chronic Urticaria: A Special Focus on COVID-19
by: Emek Kocatürk, et al.
Published: (2023-07-01)

Editorial: The complexity of urticaria
by: Michael Makris, et al.
Published: (2023-02-01)

Turkish dermatologists' approach for chronic spontaneous urticaria: A questionnaire based study
by: Emek Kocatürk, et al.
Published: (2018-06-01)

Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both
by: Yudi Chen, et al.
Published: (2021-01-01)

Follicular traction urticaria
by: Hatice Duman, et al.
Published: (2016-10-01)

Usefulness of studies looking for autoimmunity in patients with spontaneous chronic urticaria
by: María Isabel Rojo-Gutiérrez, et al.
Published: (2015-07-01)

IgE mediated autoallergy against thyroid peroxidase--a novel pathomechanism of chronic spontaneous urticaria?
by: Sabine Altrichter, et al.
Published: (2011-01-01)

Urticaria in Pregnancy and Lactation
by: Emek Kocatürk, et al.
Published: (2022-07-01)

STAT3 gain-of-function is not responsible for low total IgE levels in patients with autoimmune chronic spontaneous urticaria
by: Merle Sauer, et al.
Published: (2022-07-01)

Gut microbiota facilitate chronic spontaneous urticaria
by: Lei Zhu, et al.
Published: (2024-01-01)

Successful Treatment of a Bullous Urticaria with Omalizumab
by: Ayse Bilge Ozturk, et al.
Published: (2014-01-01)

A positive serum basophil histamine release assay is a marker for ciclosporin-responsiveness in patients with chronic spontaneous urticaria
by: Iqbal Kamran, et al.
Published: (2012-10-01)

Case Report: Omalizumab for Chronic Spontaneous Urticaria in Pregnancy
by: Shuang-Lu Liao, et al.
Published: (2021-03-01)

Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: can we define better-responding endotypes?
by: Emek Kocatürk, et al.
Published: (2022-09-01)

Management of chronic spontaneous urticaria: a worldwide perspective
by: Pavel Kolkhir, et al.
Published: (2018-07-01)

Biomarkers In Chronic Spontaneous Urticaria: Current Targets And Clinical Implications
by: Puxeddu I, et al.
Published: (2019-09-01)

The many faces of pediatric urticaria
by: Bulent Enis Sekerel, et al.
Published: (2023-11-01)

The Expression of IL-17, in Chronic Spontaneous Urticaria Is Linked to Semaphorin5A
by: Matanis Lobna, et al.
Published: (2021-03-01)

Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status
by: Thomas B. Casale, et al.
Published: (2023-09-01)

Why a Complete Response Is the Treatment Aim in Chronic Spontaneous Urticaria
by: Jonathan A. Bernstein, et al.
Published: (2023-05-01)

Thyroid disorders in spontaneous chronic urticaria
by: Patricia María O´Farrill-Romanillos, et al.
Published: (2019-11-01)

Chronic spontaneous urticaria: An etiopathogenic study
by: Apoorva Maheshwari, et al.
Published: (2022-01-01)

Autoimmune Theories of Chronic Spontaneous Urticaria
by: Sonali J. Bracken, et al.
Published: (2019-03-01)

Ligelizumab improves sleep interference and disease burden in patients with chronic spontaneous urticaria
by: Ana Giménez‐Arnau, et al.
Published: (2022-02-01)

Ligelizumab improves angioedema, disease severity and quality-of-life in patients with chronic spontaneous urticaria
by: Martin Metz, MD, et al.
Published: (2022-11-01)

Chronic spontaneous urticaria activity, impact and control as well as their changes are strongly linked, and these links are not affected by angioedema or comorbid inducible urticaria – Results from the validation of the Polish Urticaria Control Test
by: Zenon Brzoza, MD, PhD, et al.
Published: (2022-03-01)

The analysis of blood routine related indicators of acute urticaria and chronic spontaneous urticaria
by: Xiao-hui LI, et al.
Published: (2019-12-01)

Complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumab
by: Changhua Zhu, MD, et al.
Published: (2023-02-01)

Omalizumab for the management of refractory chronic spontaneous urticaria
by: P C Kathuria, et al.
Published: (2022-01-01)

Sleep quality in patients with chronic spontaneous urticaria
by: Fatma Etgü, et al.
Published: (2023-06-01)

Omalizumab in treatment-resistant chronic spontaneous urticaria
by: Kiran V Godse
Published: (2011-01-01)

Profile of omalizumab in the treatment of chronic spontaneous urticaria
by: Labrador-Horrillo M, et al.
Published: (2015-08-01)

Fexofenadine in higher doses in chronic spontaneous urticaria
by: Kiran V Godse, et al.
Published: (2010-01-01)